Novartis reported $890M in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amgen AMGN:US USD 32.37B 1.03B
Astrazeneca AZN:US USD 387M 0
AstraZeneca AZN:LN USD 387M 0
Biogen BIIB:US USD 100K 0
Bristol Myers Squibb BMY:US USD 292M 0
Canopy Growth Corp WEED:CN CAD 7.82B 216.52M
Catalent CTLT:US USD 2M 0
Corcept Therapeutics CORT:US USD 130K 2K
Drreddys Laboratories RDY:US INR 833M 1000K
Eli Lilly And LLY:US USD 594.1M 0
Endo International Ordinary Shares ENDP:US USD 63K 3K
Gilead Sciences GILD:US USD 1000K 0
Glaxosmithkline GSK:US GBP 1.35B 292.96M
GlaxoSmithKline GSK:LN GBP 1.35B 0
Horizon Pharma HZNP:US USD 23K 0
Lannett LCI:US USD 43K 1000
Merk MRK:US USD 1.79B 0
Novartis NOVN:VX USD 890M 0
Pacira Pharmaceuticals PCRX:US USD 46K 0
Perrigo Ordinary Shares PRGO:US USD 6.96B 27.4M
Pfizer PFE:US USD 476M 0
Phibro Animal Health PAHC:US USD 4K 0
Prestige Brands PBH:US USD 547K 0
Roche Holding ROG:VX 107M 53M
Supernus Pharmaceuticals SUPN:US USD 54K 1000
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Valeant Pharmaceuticals VRX:CN USD 10.39B 7M
Zoetis ZTS:US USD 5M 0